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Article Information  ABSTRACT 
Received: 12th December 2017  This research revealed that the numbers of available heterocyclic compounds are mainly focused 
on nitrogen containing compounds, such as quinazolines, indoles, benzimidazole, quinoxalines, 
coumarins and pyrimidines etc. A mixture of substituted aldehydes (0.01 mol) like acetyl acetone 
(method 1) or ethyl acetoacetate (method 2), urea or thiourea (0.01 mol) and lemon juice (0.5 ml) 
were taken into a round bottom flask and reflux for 1 hour at 800C under continuous stirring. 
After completion of the reaction the final product was recrystalized for purification. 
Simultaneously toxicity and anti-inflammatory activity were performed. But in case of using 
ethyl acetoacetate in method 2, the percentage yield was more as compare to using of acetyl 
acetone in method 1. So the derivatives obtained from method 2 were selected for further toxicity 
and anti- inflammatory activities.   
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INTRODUCTION 
Medicinal chemistry is an applied science with fundamental 
roots originating from all branches of chemistry and biology. 
The term "pharmaceutical chemistry" is often substituted for 
"medicinal chemistry" where the compounding of drugs to 
materials useful in pharmacy commands considerable attention 
[1–3]. Dihydropyrimidinones are useful targets in chemical 
synthesis  as they have been associated with a diverse range of 
therapeutic and medicinal properties [4–6]. The dihydro-
pyrimidinone scaffold is also found in various marine 
alkaloids, which have been shown to possess antiviral, 
antitumor, antibacterial and antioxidant activities [7–9]. In 
particular, the batzelladine alkaloids are known to be potent 
HIV gp-120-CD4 inhibitors. In general dihydropyrimidinones 
act as anticancer, calcium channel blockers, antibacterial, α1a-
adrenergic receptor antagonist such as monestrol, oxomonestrol 
etc. Because of heterocyclic moiety these compounds 
producing pharmacological activity [10 – 13] as per the 
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literature survey dihyropyrimidinone derivatives are 
synthesized in different methods. Members of the pyrimidinone 
family had a wide range of application in medicinal chemistry 
those are used as antimalarial, anticancer, antibacterial, 
antihypertensive, calcium channel blockers, potassium channel 
antagonists [14, 15]  
Aims of our research work is to 
 Synthesize some new dihydropyrimidinones derived 
aldehydes  
 Perform oral toxicity study and  
 Evaluate the anti-inflammatory activities of those derivatives 
 
MATERIALS & METHODS 
Materials 
Ethyl acetoacetate was purchased from Finar Chemical, 
Hyderabad, India. Urea and Thiourea were purchased from 
SDFCL, Mumbai, India.Wistar rats were purchased from NIN, 
Hyderabad, India. Tween 80 and Sodium Chloride were 
purchased from Asian Chemicals, Hyderabad, India. 
Carrageenan was purchased from Sigma India, Mumbai, India. 
Lemon juice. Water for injection and Distilled water were 
purchased from local market. Reference standard, 
Indomethacin was purchased from Sterkem Pharna (Pvt.) Ltd., 
Mumbai, India.  
Synthesis of Dihydropyrimidinones Derivatives 
Method 1: Mixture of substituted aldehydes (0.01 mol) like 
Acetyl acetone (0.01 mol), urea or thiourea (0.01 mol) and 
lemon juice (0.5 ml) were taken into a round bottom flask. 
Then this mixture was refluxed for 1½ hours (90 minutes) at 
120°C under continuous stirring. Completion of the reaction 
was monitored by TLC. Then cold water was added into the 
reaction mixture with continuous shaking for 10 minutes. Then 
it was filtered, washed with water and dried in vacuum. The 
obtained product was further recrystallized by ethanol (Figure 
1). 
 
Method 2: In a typical experimental procedure, a mixture of 
substituted aldehydes (0.01 mol), Ethyl acetoacetate (0.01 
mol), urea or thiourea (0.01 mol) and lemon juice (0.5 ml) were 
taken into a round bottom flask. Then this mixture was refluxed 
for 1 hour at 80
0 
C under continuous stirring. Completion of the 
reaction was monitored by TLC. Then cold water was added 
into the reaction mixture and stirring continuously for 10 
minutes. Then it was filtered, washed with water and dried in 
vacuum. The obtained product was further recrystalized by 
ethanol (Figure 2). 
 
Figure 1. Synthesis of Dihydropyrimidinones Derivatives by Method 1 
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Figure 2. Synthesis of Dihydropyrimidinones Derivatives by Method 2 
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Anti Inflammatory Study of Dihydropyrimidinones 
Derivatives 
Acute inflammatory model-carrageen an induced rat paws 
edema assay[16–17]   
The anti-inflammatory activity of the test compounds was 
evaluated in Wistar male albino rats employing the method. 
Male wistar rats were used for the study. Animals were kept in 
fasting condition for overnight and were divided into control, 
standard and different test groups each consisting of six 
animals. The different test compounds were administered to the 
animals in the test group at the dose of 100 mg/kg by oral 
route. Animals in the standard set acknowledged indomethacin 
at the dose of 10 mg/kg by oral route. All test and standard 
compounds were administered through vehicle (1% sodium 
carboxy methyl cellulose). The control group rats were 
received the vehicle solution without drugs. After One hour test 
drugs were administrated to all the groups of rats were 
observed with 0.1 ml of 1% carrageenan in the sub plantar 
region of right hind paw. By using digital plethysmometer to 
measure at zero hour paw volume for the rats after 
administration. The percentage inhibition of paw volume for 
each groups were calculated by comparing with mean paw 
volume of control group. It was articulated as mean percent 
inhibition of paw volume for each test group. 
 Percent oedema inhibition = 100(1-Vt/Vc) 
 Vc = Volume of oedema in the control group 
            Vt = Volume of oedema in the treated group 
 
Acute oral toxicity- acute toxic class method [17–18] 
Toxicity study was performed stepwise by using five male rats. 
The rats were fasted earlier before administration of dose. The 
synthesized compounds were suspended in Tween-80. Then it 
was administered orally in a dose of up to 150 mg/kg body 
weight.  The animals were kept under observation for 14 days. 
No transience was reported up to the dose of 100 mg/kg body 
weight of individual rat and a toxicity activity was reported in 
case of dose for 150 mg/kg body weight of individual rat.  
 
RESULTS & DISCUSSIONS  
The yield percentage of Dihydropyrimidinones derivatives 
were found 56.5% and 88.3% respectively by Method 1 and 
Method 2. Hence better results were observed in method 2 than 
method 1 and so method 2 was considered for further 
investigation. The acute Oral toxicity study of 
Dihydropyrimidinones derivatives prepared by method 2 was 
carried out by as per the OECD guidelines-423. The initial dose 
was 5 mg per kg and maximum dose was 150 mg/kg body 
weight of rat. After toxicity studies it was observed that when 
dose was 150 mg/kg body weight, the toxic effects were 
observed in the body of rats. So the dose of 100 mg/kg body 
weight was considered as maximum dose for anti- 
inflammatory activity studies. The toxicity study report was 
given in table 1.  
Table 1: Rats used for toxicity studies 
Testing animals  Dose of the test drug Toxicity 
Head marking 5mg/kg No 
Body marking 10 mg/kg No 
Tail marking 50 mg/kg No 
Head and body marking 100 mg/kg No 
Head and tail marking 150 mg/kg Yes 
 
Anti-inflammatory activity of Dihydropyrimidinones 
derivatives obtained by method 2. As per the % yield Method 2 
was selected for the animal study. All 7 newly synthesized 
compounds (DP-1 to 7) were evaluated accurately with 
maintaining the proper conditions. Among them some 
compounds (dP-3, 6, 7) had shown significant reduction in paw 
oedema which are shown in table 2. 
 
The Dihydropyrimidinones derivatives obtained by method 2 
were found to be economic (Percentage of yield was 88.3%) as 
well as less time consuming. Toxicity study was performed 
using male rats.Anti-inflammatory studies were performed for 
those synthesized compounds by carrageenan induced paw 
oedema method and compared with standard indomethacin 
drug. It was confirmed that potent to moderately potent anti-
inflammatory activities were observed by those synthesized 
compounds obtained from method 2. Among those compounds, 
DP 3, 6 and 7 using standard dose 100 mg per kg body weight 
of male rats had significant reduction activity in paw oedema as 
compare to compounds P 2, 4 and 5.  The compounds DP 3, 6 
and 7 showed 76-79% protection and compounds P1, 2, 4, and 
5 showed 64-74 % protection in our present investigation.  
 
It was concluded that prominent activity has been shown the 
compounds bearing nitro and chloro groups as compare to 
other Dihydropyrimidinones derivatives where those groups 
were absent. It was also confirmed that the groups in para 
position showed better activity as compare to the groups in 
ortho position. 
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Table 2. Carrageenan induced Paw Oedema method 
Group 1 hr. 2 hr. 3 hr. 4 hr. 5 hr. 
Control 1% Water (1 
ml/kg) 
0.32+0.01 0.58+0.04 0.64+0.02 0.72+0.01 0.84+0.02 
dP-1 (100 mg/kg) 
0.30+0.02 
 (7.28%) 
0.46+0.01 
(20.26%) 
0.57+0.03 
(38.06%) 
0.26+0.04 
 (52.24%) 
0.22+0.02 
(64.38%) 
dP-2  (100mg/kg) 
0.29+0.03 
 (8.26%) 
0.48+0.02 
(20.86%) 
0.57+0.03 
(38.42%) 
0.21+0.01 
(66.46%) 
0.16+0.04 
(72.64%) 
dP-3 (100mg/kg) 
0.26+0.02 
(8.42%) 
0.52+0.04 
(09.10%) 
0.56+0.02 
(40.48%) 
0.28+0.03 
(65.29%) 
0.19+0.02 
(79.42%) 
dP-4 (100mg/kg) 
0.31+0.01 
 (06.52%) 
0.50+0.03 
(28.46%) 
0.52+0.04 
(34.28%) 
0.26+0.02 
(58.14%) 
0.21+0.01 
(75.28%) 
dP-5  (100 mg/kg) 
0.28+0.02 
(10.24%)as p 
0.52+0.03 
(28.21%) 
0.34+0.02 
(47.60%) 
0.28+0.01 
(64.64%) 
0.18+0.02 
(73.84%) 
dP-6 (100mg/kg) 
0.28+0.03 
(10.86%) 
0.53+0.04 
(29.64%) 
0.35+0.02 
(40.52%) 
0.29+0.02 
(63.86%) 
0.17+0.03 
 (76.52%) 
dP-7 (100mg/kg) 
0.30+0.01 
(10.64%) 
0.50+0.03 
(32.10%) 
0.42+0.04 
(41.48%) 
0.27+0.03 
(64.29%) 
0.16+0.01 
(78.22%) 
Standard (10 mg/kg) 
Indomethacin 
0.26+0.01 
 (15.55%) 
0.52+0.02 
(36.92%) 
0.32+0.01 
(62.40%) 
0.24+0.03 
(76.66%) 
0.15+0.02 
(82%) 
 Dp = Dihydropyrimidinone derivatives 
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